Semnur Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2022 | — | $0 | $0 |
| Mar 2022 | — | $13.7K | $16.6K |
| Jun 2022 | — | $-1.7M | $1.1M |
| Sep 2022 | — | $-1.9M | $985.6K |
| Dec 2022 | — | $-3.3M | $819.7K |
| Mar 2023 | — | $-5.2M | $579.4K |
| Jun 2023 | — | $-6.6M | $9.1K |
| Sep 2023 | — | $-7.9M | $13.5K |
| Dec 2023 | — | $-38.1M | $204.5K |
| Mar 2024 | — | $-39.6M | $1.0K |
| Jun 2024 | — | $-40.7M | $1.5K |
| Sep 2024 | — | $-42.0M | $13.0K |
| Dec 2024 | — | $-42.8M | $12.0K |
| Mar 2025 | — | $-43.4M | $7.0K |
| Jun 2025 | — | $-44.4M | $55.0K |
| Sep 2025 | — | $-14.6M | $85.0K |
| Dec 2025 | — | $-20.8M | $20.0K |
| Mar 2026 | — | $-25.3M | $103.0K |
| Jun 2026 | — | $-29.7M | $39.0K |